2026 Drug Cost Guide: Keytruda, Wegovy, Mounjaro, Zepbound, Opdivo & Imfinzi Prices

Updated U.S. drug cost data (Keytruda, Wegovy, Mounjaro, Zepbound) — Insurance, savings & 2026 trends.

Showing 1 - 6 of 9 drug pricing articles
A Haitian Family’s Journey: Getting Keytruda Treatment in the U.S. - 2026 Drug Cost Analysis

A Haitian Family’s Journey: Getting Keytruda Treatment in the U.S.

30 views

When Marie, a Haitian mother, was diagnosed with metastatic melanoma, her oncologist recommended Keytruda, a groundbreaking immunotherapy. While offering hope, the treatment’s high cost and insurance complexities posed serious challenges. This article explores the latest 2025 pricing, insurance options, and patient assistance programs that make Keytruda accessible for Haitian and U.S. families alike.

Is CAR-T Therapy Covered by Insurance in the U.S.? (2026 Update) - 2026 Drug Cost Analysis

Is CAR-T Therapy Covered by Insurance in the U.S.? (2026 Update)

8 views

CAR-T cell therapy remains one of the most promising yet expensive cancer treatments in 2026. This detailed guide explains whether insurance companies in the U.S. — including Medicare, Medicaid, and private plans — cover CAR-T therapy. We also include updated treatment prices, hospital billing comparisons, and available financial assistance options to help patients manage costs.

CAR-T Therapy Cost in 2026: How Much Does It Really Cost in the U.S.? - 2026 Drug Cost Analysis

CAR-T Therapy Cost in 2026: How Much Does It Really Cost in the U.S.?

11 views

CAR-T therapy is transforming cancer treatment—but its cost remains among the highest in modern medicine. In 2026, total U.S. treatment expenses often range from $500,000 to over $1 million, depending on hospital, insurance coverage, and side-effect management. This guide breaks down updated CAR-T therapy prices, real-world cost data, insurance options, and expert forecasts for future affordability. Learn how patients can prepare financially and explore assistance programs that make this life-saving therapy more accessible.

How Much Does Keytruda Cost with Insurance in the U.S.? - 2026 Drug Cost Analysis

How Much Does Keytruda Cost with Insurance in the U.S.?

33 views

In 2026, most patients pay between $300 and $3,000 per month depending on their plan, deductible, and location. This complete guide breaks down Keytruda prices with and without insurance, Medicare coverage, patient assistance programs, and expert insights to help Americans save on cancer treatment costs.

Keytruda Cost in 2026: What You’ll Actually Pay (Latest U.S. Data & Savings Tips) - 2026 Drug Cost Analysis

Keytruda Cost in 2026: What You’ll Actually Pay (Latest U.S. Data & Savings Tips)

37 views

In 2026, the real cost of Keytruda (pembrolizumab) continues to rise across the U.S., with list prices now reaching $11,564 per 200 mg dose or $23,590 for the 400 mg / 6-week schedule. While insurance coverage, assistance programs, and Medicare options can significantly reduce out-of-pocket costs, many American patients still face bills ranging from $1,200 to $10,000 per month, depending on their plan. This article breaks down updated Keytruda pricing data for 2026, compares infusion costs by hospital and pharmacy, explains copay assistance options, and provides the latest policy updates about potential government price negotiations. You’ll also find detailed FAQs addressing what patients in the U.S. are actually paying, how insurance affects coverage, and where to find verified cost-saving programs. Read on to discover the latest Keytruda prices, insurance breakdowns, and patient support options available in 2026.

Top 10 Most Expensive Cancer Drugs in the U.S. (2025 Update) - 2026 Drug Cost Analysis

Top 10 Most Expensive Cancer Drugs in the U.S. (2025 Update)

380 views

In 2025, cancer treatment costs in the United States remain among the highest in the world, with several oncology drugs carrying annual price tags well over $150,000. This article breaks down the Top 10 most expensive cancer drugs in the U.S., comparing per-dose and per-year costs, highlighting manufacturers, and explaining what patients actually pay after insurance. From blockbuster immunotherapies like Keytruda and Imfinzi to groundbreaking CAR-T and gene therapies priced at nearly half a million dollars per treatment, this guide provides a clear look at the latest pricing landscape and practical insights for patients navigating financial support programs.

Drug Price FAQs: Keytruda, Wegovy, Mounjaro & More

The average cost of Keytruda without insurance in 2026 is around $10,000 to $13,000 per dose. With insurance, out-of-pocket expenses can be as low as $100 depending on the coverage.

Experts expect Zepbound’s price to drop by 10–15% in 2026 as competition and insurance coverage expand. Savings cards and manufacturer programs are also expected to continue.

Wegovy costs between $25 and $150 per month with most insurance plans in the U.S. Without insurance, the price is around $1,350 monthly.

Top Drug Comparisons 2026: Keytruda, Mounjaro, Wegovy & Zepbound

Keytruda vs Opdivo

Compare the 2026 cost, effectiveness, and insurance coverage of both cancer treatments.

Compare Now

Wegovy vs Zepbound

Find out which weight-loss drug offers the best value and results in 2026.

Read Comparison

Mounjaro Savings 2026

Learn how to get the best savings and discounts for Mounjaro through insurance and cards.

See Savings